The invention relates to a pharmaceutical composition comprising bepotastine or pharmaceutically acceptable salt thereof, decongestants and/or cortiocosteroids and at least one pharmaceutically acceptable excipient, wherein the composition is formulated as nasal spray or nasal drop.